In AIDS-related lymphoma, outcomes worse with hypoalbuminemia

For patients with AIDS-related lymphoma (ARL), hypoalbuminemia predicts inferior outcome, according to a study published online June 18 in Infectious Agents and Cancer.

Jinxin Zhang, from Nanfang Hospital in Guangzhou, China, and colleagues retrospectively analyzed de novo ARL patients from 2013 to 2019 to examine factors correlating with (PFS) and overall survival (OS). Eighty-six ARL patients were enrolled and followed for a median of 34 months.

The researchers found that the OS and two-year PFS rates were 37.5 and 35.4 percent, respectively, in the cohort. Inferior survival was predicted by older age and hypoalbuminemia in multivariate models. Worse OS and two-year PFS were seen for ARL patients with hypoalbuminemia, which was associated with poor Eastern Cooperative Oncology Group performance status and a higher International Prognosis Index score.

“We showed that hypoalbuminemia is a simple and effective prognostic factor in AIDS-related lymphoma patients,” the authors write. “For ARL with hypoalbuminemia, closer follow-up and timely intervention are necessary.”

Prognostic model predicts survival in elderly with gastrointestinal diffuse large B-cell lymphoma

More information:
Abstract/Full Text

Copyright © 2022 HealthDay. All rights reserved.

In AIDS-related lymphoma, outcomes worse with hypoalbuminemia (2022, June 24)
retrieved 26 June 2022
from https://medicalxpress.com/news/2022-06-aids-related-lymphoma-outcomes-worse-hypoalbuminemia.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Source link

Back to top button